Argatroban for Preventing Occlusion and Restenosis After Extracranial Vertebral Artery Stenting

Summary

Argatroban is a selective thrombin inhibitor, and previous study had suggested that argatroban use post percutaneous coronary intervention could potentially prevent reocclusion. But there has no study on large sample of argatroban treated restenosis vertebral artery stenting. This study will test the safety and efficacy of the argatroban on prevent Occlusion and Restenosis in patients with Extracranial vertebral Artery Stenting.

Timeline

Start

2010-04

Primary completion

2011-08

Completion

2013-07

Drugs

Indications